RxDoctor Payments DataLook up a doctor →

Thomas Kislan

Optometrist · Stroudsburg, PANPI 1255319646

Payments from drug & device makers

$267,247in general payments, 2019–2025

Across 790 payments — averaging $338.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$90K
  • Sun Pharmaceutical Industries Inc.$46K
  • Bausch & Lomb Americas Inc.$39K
  • Oyster Point Pharma, Inc.$23K
  • Tarsus Pharmaceuticals, Inc.$21K
  • Alcon$10K
  • plus $39K from 33 others
$4,017in research payments, 2019–2025

Across 3 payments — averaging $1338.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$267,247 in reported general payments places this provider in the 95th percentile of 2,165 optometrist providers in Pennsylvania.

See all optometrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$945,695
Medicare patients
551
Services billed
11,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Stroudsburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →